The ESTIV Newsletter
Become member of ESTIV

Future Events

full calendar

Due to the outbreak of the COVID-19 in Europe, the ESTIV 2020 course had to be postponed to autumn 2020. Unfortunately, due to the second wave of COVID currently present in most of the EU countries, the organisers decided to arrange the course as a virtual event. The program remains without changes. We thank the participants as well as the speakers for their flexibility, enthusiasm and readiness to cope with the challenging situation.

0 Read more

Affiated Jounal – TIV

EURL ECVAM

ESTIV Congress 2022
  • 0

Due to the COVID-19 pandemic and after thoughtful deliberation we have decided to postpone the congress to 2022 instead of the previously indicated dates in 2021. We kindly ask everyone to please save the new dates: 21-25 November 2022 . In the upcoming months, we will work on updating the website and determine a new list of important dates and deadlines for the congress. We look forward to gathering again in 2022 and in the meantime we wish everyone a healthy summer break!

ESTIV Early Career Award granted to Dr. Timothy Allen
  • 0

The European Society of Toxicology In Vitro (ESTIV) will grant an early career award for the first time in 2020 and intends to do so every 2 years coinciding with its biennial conferences…

ESTIV/ASCCT Webinars in 2020

August 20th, 2020 Webinar: PubMed Abstract Sifter: a literature informatics tool for chemical research.
Presenter: Nancy C. Baker, Leidos, Inc. and US EPA

Assessing and understanding chemical effects requires assembling information from a wide variety of sources, including millions of articles in the biomedical literature. Literature informatics approaches can help researchers make use of this information in more effective ways…..

EPAA’S 3RS SCIENCE PRIZE

The European Partnership for Alternative Approaches to Animal Testing’s (EPAA) 2020 3Rs Science Prize is now open for submissions.

News

Corporate Members

mattek in Vitro Life Science Laboratories

Gold Sponsor

Affiliated Societies

Invitrom Celltox IVTS

Memorandum of Understanding